PAP
BIOA

Persistent Asset Partners’s BioAge Labs BIOA Stock Holding History

Persistent Asset Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61
Closed -$20.3K – 499
2025
Q4 		$20.3K Buy
+61
New +$541 0.01% 314

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Persistent Asset Partners's BIOA Position: Q1 2026 in Review

Persistent Asset Partners reduced its BioAge Labs (BIOA) stake by 79% in Q1 2026, selling an estimated $1.11M and leaving 15,167 shares worth $265K. The position accounts for 0.1% of the portfolio, ranked #164.

Persistent Asset Partners first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. The position peaked at $963K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Persistent Asset Partners held 15,167 shares of BioAge Labs worth $265K as of Q1 2026.
  • Persistent Asset Partners sold 57,607 BioAge Labs shares in Q1 2026, an estimated $1.11M.
  • BioAge Labs made up 0.1% of Persistent Asset Partners's portfolio in Q1 2026, its #164 holding.
  • Persistent Asset Partners first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
  • Persistent Asset Partners's BioAge Labs position peaked at $963K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.